Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant ...
Going into 2026, biotech company Ladder Bio is embracing a new identity. Formerly known as ThirdLaw Molecular, the company announced a complete rebrand last fall, revealing a different name, a new CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results